Abbreviating it to ENGN makes it easier to fool some investors into thinking that they signed a letter of intent with a NASDAQ biotech company. I didn't think they were the same, enGene is based in Canada. There may be no SAGA shares listed anywhere, but Enzolytics is claiming them as an asset. If ENZC owns $360 million worth of SAGA shares, then they must own some percentage of SAGA and its subsidiary Virogenetics.